Vaxart, Inc. (VXRT) NASDAQ
$0.90 (0.02) (-2.64%)
Market Cap: $204.72M
As of 09/18/24 04:00 PM EDT. Market closed.
Vaxart, Inc. (VXRT)
NASDAQ
$0.90
(0.02) (-2.64%)
Market Cap: $204.72M
As of 09/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Steven Lo
Full Time Employees
109
CEO Compensation (Base)
$532,500
CEO Compensation (Total)
$3.59M
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Steven Lo
Full Time Employees
109
CEO Compensation (Base)
$532,500
CEO Compensation (Total)
$3.59M
URL
Address
170 Harbor Way, CA, South San Francisco, 94080.
PRICE CHART FOR VAXART, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.93
Previous Close
$0.92
Days Range
$0.90 - $0.95
52 week range
$0.52 - $1.54
Volume
1,039,904
Avg. Volume (30 days)
2,625,748
Market Cap
$204.72M
Dividend Yield
-
P/E
(2)
Shares Outstanding
227,439,000
Open
$0.93
Previous Close
$0.92
Days Range
$0.90 - $0.95
52 week range
$0.52 - $1.54
Volume
1,039,904
Avg. Volume (30 days)
2,625,748
Market Cap
$204.72M
Dividend Yield
-
P/E
(2)
Shares Outstanding
227,439,000
FINANCIAL STATEMENTS FOR VAXART, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR VAXART, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Watson W. Mark | Director | Jun 18, 2024 | Buy | $0.68 | 20,000 | 13,578 | 78,125 | Jun 20, 2024, 06:10 AM |
| Lee Phillip E | Chief Financial Officer | Jun 12, 2024 | Option Exercise | $0.76 | 2,007 | 1,525 | 239,801 | Jun 13, 2024, 04:36 PM |
| Tucker Sean | SVP, Chief Scientific Officer | Mar 28, 2024 | Option Exercise | $1.30 | 3,902 | 5,073 | 355,695 | Apr 01, 2024, 07:16 PM |
| Cummings James F. | Chief Medical Officer | Mar 28, 2024 | Option Exercise | $1.30 | 3,292 | 4,280 | 326,801 | Apr 01, 2024, 07:13 PM |
| Tucker Sean | SVP, Chief Scientific Officer | Feb 02, 2024 | Option Exercise | $1.20 | 9,220 | 11,064 | 330,122 | Mar 20, 2024, 08:12 PM |
| Tucker Sean | SVP, Chief Scientific Officer | Dec 08, 2023 | Option Exercise | $0.71 | 34,288 | 24,344 | 339,342 | Mar 20, 2024, 08:12 PM |
| Tucker Sean | SVP, Chief Scientific Officer | Mar 28, 2023 | Option Exercise | $0.75 | 3,683 | 2,762 | 373,630 | Mar 20, 2024, 08:12 PM |
| Lee Phillip E | Chief Financial Officer | Dec 15, 2023 | Option Exercise | $0.63 | 5,943 | 3,744 | 151,808 | Mar 20, 2024, 08:10 PM |
| Lee Phillip E | Chief Financial Officer | Dec 08, 2023 | Option Exercise | $0.71 | 35,151 | 24,957 | 157,751 | Mar 20, 2024, 08:10 PM |
| Cummings James F. | Chief Medical Officer | Feb 02, 2024 | Option Exercise | $1.20 | 7,965 | 9,558 | 240,093 | Mar 20, 2024, 08:09 PM |
| Cummings James F. | Chief Medical Officer | Dec 08, 2023 | Option Exercise | $0.71 | 31,409 | 22,300 | 248,058 | Mar 20, 2024, 08:09 PM |
| Berg Edward B | SVP, General Counsel | Feb 02, 2024 | Option Exercise | $1.20 | 9,220 | 11,064 | 180,706 | Mar 20, 2024, 08:07 PM |
| Berg Edward B | SVP, General Counsel | Dec 08, 2023 | Option Exercise | $0.71 | 33,752 | 23,964 | 189,926 | Mar 20, 2024, 08:07 PM |
| Watson W. Mark | Director | Dec 28, 2022 | Buy | $0.76 | 20,000 | 15,140 | 20,000 | Dec 28, 2022, 05:25 PM |
| Yedid Robert A. | Director | Jan 10, 2022 | Sale | $6.01 | 1,500 | 9,015 | 0 | Oct 07, 2022, 05:32 PM |
| Yedid Robert A. | Director | Aug 19, 2022 | Option Exercise | $0.94 | 26,240 | 24,774 | 37,355 | Aug 22, 2022, 06:06 PM |
| Ahmad Fuad | Interim CFO | Jun 22, 2022 | Buy | $3.22 | 5,000 | 16,100 | 5,000 | Jun 23, 2022, 04:32 PM |
| Tucker Sean | SVP, Chief Scientific Officer | Apr 22, 2022 | Option Exercise | $0.77 | 40,000 | 30,800 | 127,631 | Apr 25, 2022, 04:40 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Nov 30, 2021 | Option Exercise | $1.58 | 3,602 | 5,704 | 3,602 | Dec 01, 2021, 04:05 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Nov 30, 2021 | Sale | $8.00 | 3,602 | 28,816 | 0 | Dec 01, 2021, 04:05 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Sep 10, 2021 | Option Exercise | $1.59 | 1,801 | 2,856 | 1,801 | Sep 13, 2021, 07:29 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Sep 10, 2021 | Sale | $9.10 | 1,801 | 16,389 | 0 | Sep 13, 2021, 07:29 PM |
| Tucker Sean | SVP, Chief Scientific Officer | Aug 10, 2021 | Sale | $10.20 | 5,828 | 59,446 | 51,465 | Aug 11, 2021, 06:53 PM |
| Tucker Sean | SVP, Chief Scientific Officer | Aug 10, 2021 | Sale | $10.20 | 4,172 | 42,554 | 43,881 | Aug 11, 2021, 06:53 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Aug 10, 2021 | Option Exercise | $1.58 | 1,801 | 2,852 | 1,801 | Aug 11, 2021, 06:52 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Aug 10, 2021 | Sale | $10.00 | 1,801 | 18,010 | 0 | Aug 11, 2021, 06:52 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Jul 19, 2021 | Option Exercise | $1.58 | 1,800 | 2,851 | 1,800 | Jul 21, 2021, 04:32 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Jul 19, 2021 | Sale | $8.00 | 1,800 | 14,400 | 0 | Jul 21, 2021, 04:32 PM |
| Yedid Robert A. | Director | Jun 11, 2021 | Option Exercise | $0.31 | 18,240 | 5,654 | 18,240 | Jun 14, 2021, 04:17 PM |
| Yedid Robert A. | Director | Jun 11, 2021 | Sale | $8.61 | 10,000 | 86,109 | 8,240 | Jun 14, 2021, 04:17 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Jun 11, 2021 | Option Exercise | $1.59 | 1,802 | 2,857 | 1,802 | Jun 14, 2021, 04:16 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Jun 11, 2021 | Sale | $8.00 | 1,802 | 14,416 | 0 | Jun 14, 2021, 04:16 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Jun 09, 2021 | Option Exercise | $1.91 | 47,555 | 90,883 | 47,555 | Jun 11, 2021, 04:17 PM |
| Echerd Margaret | SVP, Principal Accntng Officer | Jun 09, 2021 | Sale | $8.00 | 47,555 | 380,440 | 0 | Jun 11, 2021, 04:17 PM |
| Tucker Sean | Chief Scientific Officer | Mar 16, 2021 | Option Exercise | $6.49 | 1,006 | 6,529 | 48,053 | Mar 19, 2021, 05:04 PM |
| Latour Wouter | Director | Mar 04, 2021 | Option Exercise | $0.77 | 150,000 | 115,500 | 150,000 | Mar 05, 2021, 04:03 PM |
| Latour Wouter | Director | Mar 04, 2021 | Sale | $6.04 | 150,000 | 906,450 | 0 | Mar 05, 2021, 04:03 PM |
| Latour Wouter | Director | Nov 23, 2020 | Sale | $6.32 | 333,334 | 2,108,138 | 0 | Nov 23, 2020, 08:18 PM |
| Tucker Sean | Chief Scientific Officer | Aug 13, 2020 | Option Exercise | $6.49 | 4,026 | 26,129 | 51,679 | Aug 14, 2020, 04:21 PM |
| Latour Wouter | Director | Aug 12, 2020 | Option Exercise | $0.30 | 166,667 | 50,000 | 333,334 | Aug 12, 2020, 04:32 PM |
| ARMISTICE CAPITAL, LLC | Director | Jun 26, 2020 | Sale | $10.38 | 18,226,667 | 189,192,806 | 5,440,000 | Jun 30, 2020, 05:54 PM |
| ARMISTICE CAPITAL, LLC | Director | Jun 29, 2020 | Sale | $8.29 | 9,385,386 | 77,804,850 | 145,523 | Jun 30, 2020, 05:54 PM |
| ARMISTICE CAPITAL, LLC | Director | Jun 29, 2020 | Option Exercise | $1.10 | 4,090,909 | 4,500,000 | 9,530,909 | Jun 30, 2020, 05:54 PM |
| ARMISTICE CAPITAL, LLC | Director | Jun 26, 2020 | Option Exercise | $0.30 | 16,666,667 | 5,000,000 | 23,666,667 | Jun 30, 2020, 05:54 PM |
| ARMISTICE CAPITAL, LLC | Director | Jun 03, 2020 | Sale | $2.77 | 400,000 | 1,108,000 | 7,000,000 | Jun 03, 2020, 05:45 PM |
| ARMISTICE CAPITAL, LLC | Director | Jun 02, 2020 | Sale | $2.75 | 800,000 | 2,200,000 | 7,400,000 | Jun 03, 2020, 05:45 PM |
| ARMISTICE CAPITAL, LLC | Director | Jun 01, 2020 | Sale | $2.74 | 200,000 | 548,000 | 8,200,000 | Jun 03, 2020, 05:45 PM |
| ARMISTICE CAPITAL, LLC | Director | May 27, 2020 | Sale | $2.61 | 200,000 | 522,000 | 8,400,000 | May 29, 2020, 05:22 PM |
| ARMISTICE CAPITAL, LLC | Director | May 22, 2020 | Sale | $2.86 | 200,000 | 572,000 | 8,600,000 | May 22, 2020, 05:29 PM |
| ARMISTICE CAPITAL, LLC | Director | May 21, 2020 | Sale | $2.97 | 400,000 | 1,188,000 | 8,800,000 | May 22, 2020, 05:29 PM |
| ARMISTICE CAPITAL, LLC | Director | May 20, 2020 | Sale | $3.19 | 1,150,000 | 3,668,500 | 9,200,000 | May 22, 2020, 05:29 PM |
| ARMISTICE CAPITAL, LLC | Director | May 14, 2020 | Sale | $3.02 | 834,669 | 2,520,700 | 11,458,639 | May 18, 2020, 05:25 PM |
| ARMISTICE CAPITAL, LLC | Director | May 18, 2020 | Sale | $2.86 | 650,000 | 1,859,000 | 10,350,000 | May 18, 2020, 05:25 PM |
| ARMISTICE CAPITAL, LLC | Director | May 15, 2020 | Sale | $2.82 | 458,639 | 1,293,362 | 11,000,000 | May 18, 2020, 05:25 PM |
| ARMISTICE CAPITAL, LLC | Director | May 13, 2020 | Sale | $2.97 | 525,616 | 1,561,080 | 12,293,308 | May 13, 2020, 05:37 PM |
| ARMISTICE CAPITAL, LLC | Director | May 12, 2020 | Sale | $3.02 | 1,581,076 | 4,774,849 | 12,818,924 | May 13, 2020, 05:37 PM |
| ARMISTICE CAPITAL, LLC | Director | May 11, 2020 | Sale | $2.79 | 1,300,000 | 3,627,000 | 14,400,000 | May 13, 2020, 05:37 PM |
| ARMISTICE CAPITAL, LLC | Director | May 08, 2020 | Sale | $2.52 | 100,000 | 252,000 | 15,700,000 | May 08, 2020, 05:48 PM |
| ARMISTICE CAPITAL, LLC | Director | May 07, 2020 | Sale | $2.51 | 100,000 | 251,000 | 15,800,000 | May 08, 2020, 05:48 PM |
| ARMISTICE CAPITAL, LLC | Director | May 06, 2020 | Sale | $2.58 | 50,000 | 129,000 | 15,900,000 | May 08, 2020, 05:48 PM |
| ARMISTICE CAPITAL, LLC | Director | May 05, 2020 | Sale | $2.66 | 692,531 | 1,842,133 | 15,950,000 | May 05, 2020, 05:20 PM |
| ARMISTICE CAPITAL, LLC | Director | May 04, 2020 | Sale | $2.65 | 957,469 | 2,537,293 | 16,642,531 | May 05, 2020, 05:20 PM |
| ARMISTICE CAPITAL, LLC | Director | May 01, 2020 | Sale | $2.71 | 1,000,000 | 2,710,000 | 17,600,000 | May 05, 2020, 05:20 PM |
| ARMISTICE CAPITAL, LLC | Director | Apr 30, 2020 | Sale | $2.96 | 4,434,296 | 13,125,516 | 18,600,000 | Apr 30, 2020, 08:28 PM |
| ARMISTICE CAPITAL, LLC | Director | Apr 29, 2020 | Sale | $3.01 | 873,634 | 2,629,638 | 23,034,296 | Apr 30, 2020, 08:28 PM |
| ARMISTICE CAPITAL, LLC | Director | Apr 28, 2020 | Sale | $3.38 | 1,292,070 | 4,367,197 | 23,907,930 | Apr 30, 2020, 08:28 PM |
| Davis Todd C | Director | Apr 28, 2020 | Sale | $3.28 | 60,000 | 196,500 | 120,000 | Apr 30, 2020, 04:10 PM |
| ARMISTICE CAPITAL, LLC | Director | Nov 07, 2019 | Buy | $0.34 | 63,749 | 21,675 | 25,200,000 | Nov 07, 2019, 06:10 PM |
| ARMISTICE CAPITAL, LLC | Director | Nov 06, 2019 | Buy | $0.34 | 61,869 | 21,035 | 25,136,251 | Nov 07, 2019, 06:10 PM |
| ARMISTICE CAPITAL, LLC | Director | Nov 05, 2019 | Buy | $0.33 | 74,382 | 24,546 | 25,074,382 | Nov 07, 2019, 06:10 PM |
| Richard John P | Director | Oct 11, 2019 | Buy | $0.38 | 20,000 | 7,680 | 20,000 | Oct 15, 2019, 12:19 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Oct 07, 2019 | Buy | $0.37 | 290,000 | 107,300 | 25,000,000 | Oct 07, 2019, 06:13 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Oct 04, 2019 | Buy | $0.35 | 274,000 | 95,900 | 24,710,000 | Oct 07, 2019, 06:13 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Oct 03, 2019 | Buy | $0.34 | 228,720 | 77,765 | 24,436,000 | Oct 03, 2019, 06:15 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Oct 02, 2019 | Buy | $0.36 | 23,913 | 8,609 | 24,207,280 | Oct 03, 2019, 06:15 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Oct 01, 2019 | Buy | $0.35 | 183,367 | 64,178 | 24,183,367 | Oct 03, 2019, 06:15 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Sep 30, 2019 | Buy | $0.33 | 1,600,376 | 528,124 | 24,000,000 | Sep 30, 2019, 06:55 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Sep 27, 2019 | Buy | $0.29 | 972,643 | 282,066 | 22,399,624 | Sep 30, 2019, 06:55 PM |
| ARMISTICE CAPITAL, LLC | 10% Owner | Sep 26, 2019 | Buy | $0.28 | 4,760,314 | 1,332,888 | 21,426,981 | Sep 30, 2019, 06:55 PM |
| Latour Wouter | President and Chief Executive | Sep 30, 2019 | Buy | $0.30 | 166,667 | 50,000 | 166,667 | Sep 30, 2019, 06:11 PM |
| Tucker Sean | Chief Scientific Officer | Apr 11, 2019 | Buy | $1.10 | 27,273 | 30,000 | 52,661 | Apr 12, 2019, 06:04 PM |
| Finney Michael J. | Director | Apr 11, 2019 | Buy | $1.10 | 181,818 | 200,000 | 452,572 | Apr 12, 2019, 05:05 PM |
| Finney Michael J. | Director | Jun 05, 2018 | Buy | $3.19 | 4,000 | 12,751 | 233,978 | Jun 08, 2018, 05:32 PM |
| Finney Michael J. | Director | Jun 04, 2018 | Buy | $4.27 | 1,000 | 4,270 | 229,978 | Jun 08, 2018, 05:32 PM |
| Tucker Sean | Chief Scientific Officer | Mar 12, 2018 | Option Exercise | $6.49 | 2,013 | 13,064 | 47,653 | Mar 14, 2018, 09:11 PM |
| COLONNESE MARK P | Chief Financial Officer | Feb 09, 2016 | Buy | $1.41 | 7,000 | 9,847 | 7,000 | Feb 09, 2016, 04:09 PM |
| PATTI JOSEPH M | CEO | Sep 25, 2015 | Buy | $1.87 | 5,000 | 9,338 | 126,128 | Sep 28, 2015, 03:54 PM |
| PLUMB RUSSELL H | Executive Chairman | Sep 16, 2015 | Option Exercise | $2.49 | 12,140 | 30,229 | 203,213 | Sep 18, 2015, 11:54 AM |
| Fox James | Director | Aug 11, 2015 | Option Exercise | $2.49 | 2,500 | 6,225 | 2,500 | Aug 13, 2015, 04:53 PM |
| VANLENT ANNE | Director | Jun 22, 2015 | Buy | $2.20 | 35,000 | 76,891 | 35,000 | Jun 24, 2015, 04:00 PM |
| Fox James | Director | Jun 10, 2015 | Buy | $2.03 | 70,000 | 142,100 | 100,614 | Jun 15, 2015, 04:18 PM |
| Fox James | Director | Jun 09, 2015 | Buy | $1.99 | 70,000 | 139,300 | 100,614 | Jun 11, 2015, 05:13 PM |
| Fox James | Director | May 12, 2015 | Option Exercise | $2.20 | 7,500 | 16,500 | 7,500 | May 14, 2015, 04:13 PM |
| PATTI JOSEPH M | CEO | Mar 27, 2015 | Buy | $2.28 | 20,000 | 45,689 | 121,128 | Mar 31, 2015, 04:00 PM |
| PLUMB RUSSELL H | Vice Chairmen | Oct 01, 2014 | Option Exercise | $2.45 | 40,000 | 98,000 | 40,000 | Oct 02, 2014, 04:43 PM |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 30, 2014 | Buy | $2.86 | 10,000 | 28,600 | 68,241 | Jul 02, 2014, 12:56 PM |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 27, 2014 | Buy | $2.81 | 5,000 | 14,026 | 67,241 | Jun 30, 2014, 03:20 PM |
| PLUMB RUSSELL H | CEO & President | Jun 11, 2014 | Buy | $3.04 | 29,331 | 89,077 | 127,579 | Jun 12, 2014, 04:06 PM |
| PLUMB RUSSELL H | CEO & President | Jun 10, 2014 | Buy | $2.45 | 2,700 | 6,615 | 98,248 | Jun 12, 2014, 04:06 PM |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 11, 2014 | Buy | $2.88 | 5,616 | 16,172 | 62,241 | Jun 12, 2014, 04:05 PM |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | Jun 10, 2014 | Buy | $2.46 | 8,851 | 21,753 | 56,625 | Jun 12, 2014, 04:05 PM |
| Fox James | Director | May 15, 2014 | Option Exercise | $2.85 | 7,500 | 21,375 | 7,500 | May 20, 2014, 02:55 PM |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | Apr 05, 2012 | Sale | $1.90 | 5,167 | 9,817 | 105,128 | Apr 09, 2012, 04:21 PM |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | May 16, 2011 | Sale | $5.51 | 12,376 | 68,159 | 115,171 | May 18, 2011, 10:39 AM |
| FAHIM RAAFAT E F | President, CEO and CFO | Nov 30, 2010 | Option Exercise | $4.30 | 3,023 | 12,999 | 336,757 | Apr 05, 2011, 05:25 PM |
| FAHIM RAAFAT E F | President, CEO and CFO | May 31, 2010 | Option Exercise | $4.20 | 3,096 | 13,003 | 333,734 | Apr 05, 2011, 05:25 PM |
| FAHIM RAAFAT E F | President, CEO and CFO | Apr 05, 2011 | Sale | $5.76 | 13,283 | 76,458 | 373,474 | Apr 05, 2011, 05:25 PM |
| Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | Apr 01, 2011 | Sale | $5.80 | 6,300 | 36,530 | 41,050 | Apr 05, 2011, 05:18 PM |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | Apr 05, 2011 | Sale | $5.76 | 8,596 | 49,479 | 122,671 | Apr 05, 2011, 05:13 PM |
| Aryeh Jason | Director | Mar 15, 2011 | Sale | $5.87 | 4,900 | 28,763 | 131,783 | Mar 17, 2011, 03:32 PM |
| Aryeh Jason | Director | Mar 14, 2011 | Sale | $5.83 | 3,400 | 19,828 | 137,683 | Mar 16, 2011, 06:31 PM |
| Aryeh Jason | Director | Mar 11, 2011 | Sale | $5.76 | 24,700 | 142,171 | 154,883 | Mar 15, 2011, 06:31 PM |
| FAHIM RAAFAT E F | President, CEO and CFO | Jan 05, 2011 | Sale | $5.65 | 3,181 | 17,973 | 330,638 | Jan 07, 2011, 03:21 PM |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | Jan 05, 2011 | Sale | $5.65 | 2,985 | 16,869 | 95,267 | Jan 07, 2011, 03:16 PM |
| Aryeh Jason | Director | Dec 27, 2010 | Sale | $5.74 | 15,093 | 86,634 | 0 | Dec 29, 2010, 06:42 PM |
| Aryeh Jason | Director | Dec 15, 2010 | Sale | $5.74 | 1,907 | 10,946 | 15,093 | Dec 29, 2010, 06:39 PM |
| Aryeh Jason | Director | Dec 15, 2010 | Sale | $5.74 | 1,907 | 10,946 | 179,876 | Dec 17, 2010, 07:12 PM |
| Aryeh Jason | Director | Dec 08, 2010 | Sale | $5.49 | 4,705 | 25,830 | 181,783 | Dec 10, 2010, 04:53 PM |
| Aryeh Jason | Director | Dec 01, 2010 | Sale | $5.53 | 6,700 | 37,051 | 186,488 | Dec 03, 2010, 04:49 PM |
| Aryeh Jason | Director | Nov 22, 2010 | Sale | $5.25 | 2,832 | 14,868 | 193,188 | Nov 22, 2010, 06:18 PM |
| Aryeh Jason | Director | Nov 19, 2010 | Sale | $5.25 | 463 | 2,431 | 196,020 | Nov 22, 2010, 06:18 PM |
| Aryeh Jason | Director | Nov 18, 2010 | Sale | $5.24 | 4,900 | 25,676 | 196,483 | Nov 22, 2010, 06:18 PM |
| Aryeh Jason | Director | Nov 11, 2010 | Sale | $5.30 | 4,900 | 25,970 | 201,383 | Nov 15, 2010, 06:36 PM |
| Aryeh Jason | Director | Nov 10, 2010 | Sale | $5.39 | 11,200 | 60,402 | 206,283 | Nov 12, 2010, 06:32 PM |
| Aryeh Jason | Director | Nov 09, 2010 | Sale | $5.26 | 6,400 | 33,677 | 217,483 | Nov 12, 2010, 06:32 PM |
| Aryeh Jason | Director | Oct 20, 2010 | Sale | $5.01 | 8,553 | 42,851 | 223,883 | Oct 20, 2010, 05:58 PM |
| Aryeh Jason | Director | Oct 18, 2010 | Sale | $5.00 | 12,020 | 60,100 | 232,436 | Oct 20, 2010, 05:58 PM |
| Aryeh Jason | Director | Oct 11, 2010 | Sale | $5.00 | 4,422 | 22,110 | 244,456 | Oct 13, 2010, 05:33 PM |
| Aryeh Jason | Director | Jun 11, 2010 | Sale | $5.74 | 600 | 3,446 | 248,878 | Aug 19, 2010, 06:08 PM |
| Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | Jul 26, 2010 | Sale | $5.78 | 1,500 | 8,670 | 44,225 | Jul 27, 2010, 04:27 PM |
| Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | Jul 19, 2010 | Sale | $5.48 | 1,625 | 8,905 | 45,725 | Jul 21, 2010, 06:03 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Watson W. Mark | Director | 06/18/2024 | 13,578 |
| Lee Phillip E | Chief Financial Officer | 06/12/2024 | 1,525 |
| Tucker Sean | SVP, Chief Scientific Officer | 03/28/2024 | 5,073 |
| Cummings James F. | Chief Medical Officer | 03/28/2024 | 4,280 |
| Tucker Sean | SVP, Chief Scientific Officer | 02/02/2024 | 11,064 |
| Tucker Sean | SVP, Chief Scientific Officer | 12/08/2023 | 24,344 |
| Tucker Sean | SVP, Chief Scientific Officer | 03/28/2023 | 2,762 |
| Lee Phillip E | Chief Financial Officer | 12/15/2023 | 3,744 |
| Lee Phillip E | Chief Financial Officer | 12/08/2023 | 24,957 |
| Cummings James F. | Chief Medical Officer | 02/02/2024 | 9,558 |
| Cummings James F. | Chief Medical Officer | 12/08/2023 | 22,300 |
| Berg Edward B | SVP, General Counsel | 02/02/2024 | 11,064 |
| Berg Edward B | SVP, General Counsel | 12/08/2023 | 23,964 |
| Watson W. Mark | Director | 12/28/2022 | 15,140 |
| Yedid Robert A. | Director | 01/10/2022 | 9,015 |
| Yedid Robert A. | Director | 08/19/2022 | 24,774 |
| Ahmad Fuad | Interim CFO | 06/22/2022 | 16,100 |
| Tucker Sean | SVP, Chief Scientific Officer | 04/22/2022 | 30,800 |
| Echerd Margaret | SVP, Principal Accntng Officer | 11/30/2021 | 5,704 |
| Echerd Margaret | SVP, Principal Accntng Officer | 11/30/2021 | 28,816 |
| Echerd Margaret | SVP, Principal Accntng Officer | 09/10/2021 | 2,856 |
| Echerd Margaret | SVP, Principal Accntng Officer | 09/10/2021 | 16,389 |
| Tucker Sean | SVP, Chief Scientific Officer | 08/10/2021 | 59,446 |
| Tucker Sean | SVP, Chief Scientific Officer | 08/10/2021 | 42,554 |
| Echerd Margaret | SVP, Principal Accntng Officer | 08/10/2021 | 2,852 |
| Echerd Margaret | SVP, Principal Accntng Officer | 08/10/2021 | 18,010 |
| Echerd Margaret | SVP, Principal Accntng Officer | 07/19/2021 | 2,851 |
| Echerd Margaret | SVP, Principal Accntng Officer | 07/19/2021 | 14,400 |
| Yedid Robert A. | Director | 06/11/2021 | 5,654 |
| Yedid Robert A. | Director | 06/11/2021 | 86,109 |
| Echerd Margaret | SVP, Principal Accntng Officer | 06/11/2021 | 2,857 |
| Echerd Margaret | SVP, Principal Accntng Officer | 06/11/2021 | 14,416 |
| Echerd Margaret | SVP, Principal Accntng Officer | 06/09/2021 | 90,883 |
| Echerd Margaret | SVP, Principal Accntng Officer | 06/09/2021 | 380,440 |
| Tucker Sean | Chief Scientific Officer | 03/16/2021 | 6,529 |
| Latour Wouter | Director | 03/04/2021 | 115,500 |
| Latour Wouter | Director | 03/04/2021 | 906,450 |
| Latour Wouter | Director | 11/23/2020 | 2,108,138 |
| Tucker Sean | Chief Scientific Officer | 08/13/2020 | 26,129 |
| Latour Wouter | Director | 08/12/2020 | 50,000 |
| ARMISTICE CAPITAL, LLC | Director | 06/26/2020 | 189,192,806 |
| ARMISTICE CAPITAL, LLC | Director | 06/29/2020 | 77,804,850 |
| ARMISTICE CAPITAL, LLC | Director | 06/29/2020 | 4,500,000 |
| ARMISTICE CAPITAL, LLC | Director | 06/26/2020 | 5,000,000 |
| ARMISTICE CAPITAL, LLC | Director | 06/03/2020 | 1,108,000 |
| ARMISTICE CAPITAL, LLC | Director | 06/02/2020 | 2,200,000 |
| ARMISTICE CAPITAL, LLC | Director | 06/01/2020 | 548,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/27/2020 | 522,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/22/2020 | 572,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/21/2020 | 1,188,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/20/2020 | 3,668,500 |
| ARMISTICE CAPITAL, LLC | Director | 05/14/2020 | 2,520,700 |
| ARMISTICE CAPITAL, LLC | Director | 05/18/2020 | 1,859,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/15/2020 | 1,293,362 |
| ARMISTICE CAPITAL, LLC | Director | 05/13/2020 | 1,561,080 |
| ARMISTICE CAPITAL, LLC | Director | 05/12/2020 | 4,774,849 |
| ARMISTICE CAPITAL, LLC | Director | 05/11/2020 | 3,627,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/08/2020 | 252,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/07/2020 | 251,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/06/2020 | 129,000 |
| ARMISTICE CAPITAL, LLC | Director | 05/05/2020 | 1,842,133 |
| ARMISTICE CAPITAL, LLC | Director | 05/04/2020 | 2,537,293 |
| ARMISTICE CAPITAL, LLC | Director | 05/01/2020 | 2,710,000 |
| ARMISTICE CAPITAL, LLC | Director | 04/30/2020 | 13,125,516 |
| ARMISTICE CAPITAL, LLC | Director | 04/29/2020 | 2,629,638 |
| ARMISTICE CAPITAL, LLC | Director | 04/28/2020 | 4,367,197 |
| Davis Todd C | Director | 04/28/2020 | 196,500 |
| ARMISTICE CAPITAL, LLC | Director | 11/07/2019 | 21,675 |
| ARMISTICE CAPITAL, LLC | Director | 11/06/2019 | 21,035 |
| ARMISTICE CAPITAL, LLC | Director | 11/05/2019 | 24,546 |
| Richard John P | Director | 10/11/2019 | 7,680 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 10/07/2019 | 107,300 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 10/04/2019 | 95,900 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 10/03/2019 | 77,765 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 10/02/2019 | 8,609 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 10/01/2019 | 64,178 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 09/30/2019 | 528,124 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 09/27/2019 | 282,066 |
| ARMISTICE CAPITAL, LLC | 10% Owner | 09/26/2019 | 1,332,888 |
| Latour Wouter | President and Chief Executive | 09/30/2019 | 50,000 |
| Tucker Sean | Chief Scientific Officer | 04/11/2019 | 30,000 |
| Finney Michael J. | Director | 04/11/2019 | 200,000 |
| Finney Michael J. | Director | 06/05/2018 | 12,751 |
| Finney Michael J. | Director | 06/04/2018 | 4,270 |
| Tucker Sean | Chief Scientific Officer | 03/12/2018 | 13,064 |
| COLONNESE MARK P | Chief Financial Officer | 02/09/2016 | 9,847 |
| PATTI JOSEPH M | CEO | 09/25/2015 | 9,338 |
| PLUMB RUSSELL H | Executive Chairman | 09/16/2015 | 30,229 |
| Fox James | Director | 08/11/2015 | 6,225 |
| VANLENT ANNE | Director | 06/22/2015 | 76,891 |
| Fox James | Director | 06/10/2015 | 142,100 |
| Fox James | Director | 06/09/2015 | 139,300 |
| Fox James | Director | 05/12/2015 | 16,500 |
| PATTI JOSEPH M | CEO | 03/27/2015 | 45,689 |
| PLUMB RUSSELL H | Vice Chairmen | 10/01/2014 | 98,000 |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | 06/30/2014 | 28,600 |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | 06/27/2014 | 14,026 |
| PLUMB RUSSELL H | CEO & President | 06/11/2014 | 89,077 |
| PLUMB RUSSELL H | CEO & President | 06/10/2014 | 6,615 |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | 06/11/2014 | 16,172 |
| PATTI JOSEPH M | EVP, Corporate Dev & Strategy | 06/10/2014 | 21,753 |
| Fox James | Director | 05/15/2014 | 21,375 |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | 04/05/2012 | 9,817 |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | 05/16/2011 | 68,159 |
| FAHIM RAAFAT E F | President, CEO and CFO | 11/30/2010 | 12,999 |
| FAHIM RAAFAT E F | President, CEO and CFO | 05/31/2010 | 13,003 |
| FAHIM RAAFAT E F | President, CEO and CFO | 04/05/2011 | 76,458 |
| Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | 04/01/2011 | 36,530 |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | 04/05/2011 | 49,479 |
| Aryeh Jason | Director | 03/15/2011 | 28,763 |
| Aryeh Jason | Director | 03/14/2011 | 19,828 |
| Aryeh Jason | Director | 03/11/2011 | 142,171 |
| FAHIM RAAFAT E F | President, CEO and CFO | 01/05/2011 | 17,973 |
| Kessler Paul D. | SVP Clinical, Med. & Reg.; CMO | 01/05/2011 | 16,869 |
| Aryeh Jason | Director | 12/27/2010 | 86,634 |
| Aryeh Jason | Director | 12/15/2010 | 10,946 |
| Aryeh Jason | Director | 12/15/2010 | 10,946 |
| Aryeh Jason | Director | 12/08/2010 | 25,830 |
| Aryeh Jason | Director | 12/01/2010 | 37,051 |
| Aryeh Jason | Director | 11/22/2010 | 14,868 |
| Aryeh Jason | Director | 11/19/2010 | 2,431 |
| Aryeh Jason | Director | 11/18/2010 | 25,676 |
| Aryeh Jason | Director | 11/11/2010 | 25,970 |
| Aryeh Jason | Director | 11/10/2010 | 60,402 |
| Aryeh Jason | Director | 11/09/2010 | 33,677 |
| Aryeh Jason | Director | 10/20/2010 | 42,851 |
| Aryeh Jason | Director | 10/18/2010 | 60,100 |
| Aryeh Jason | Director | 10/11/2010 | 22,110 |
| Aryeh Jason | Director | 06/11/2010 | 3,446 |
| Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | 07/26/2010 | 8,670 |
| Kalnik Matthew W. | SVP Strategic Plan. & Bus. Ops | 07/19/2010 | 8,905 |
Load More Insider Transactions
FUNDS WITH A POSITION IN VAXART, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 15,384,615 | 0.26% | Exited | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 2,196,503 | 0.00013% | 0.07% | Other |
| BLACKROCK INC. | 1,774,346 | 0.00003% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 847,631 | 0.00096% | -8.29% | Other |
| D. E. SHAW & CO., INC. | 174,606 | 0.00019% | Exited | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 48,980 | 0.00011% | Exited | Event Driven |
| FISHER ASSET MANAGEMENT, LLC | 10,270 | 0% | New | Other |
CHANGE IN SHARES OUTSTANDING FOR VAXART, INC.
STOCK BUYBACKS FOR VAXART, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2024
9.41%
1Q
12/31/2023
20.36%
2Q
09/30/2023
21.49%
3Q
06/30/2023
32.31%
4Q
03/31/2023
36.60%
5Q
12/31/2022
39.00%
6Q
09/30/2022
45.56%
7Q
06/30/2022
46.09%
8Q
03/31/2022
46.83%
9Q
12/31/2021
47.19%
10Q
09/30/2021
48.97%
11Q
06/30/2021
52.74%
12Q
03/31/2021
60.02%
13Q
12/31/2020
68.43%
14Q
09/30/2020
71.47%
15Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR VAXART, INC.
LOADING...